Water

Water

SCHEMBL580997

O.[NaH].[PbH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL3644096 0.82
Water SCHEMBL11059872 0.82
Water SCHEMBL8167950 0.82
Water SCHEMBL8745540 0.82
Water SCHEMBL11845423 0.82
Water SCHEMBL25405214 0.82
Water SCHEMBL5802169 0.82
Water SCHEMBL1983786 0.82
Water SCHEMBL11178140 0.82
Water SCHEMBL9297984 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658076-A1 ANTISEPTIC CONDITIONING FORMULATIONS Thommen Medical AG (CH) 2025-12-10 EP disclosed
CN-120158617-A Method for enriching and recovering lead from lead sulfate slag 贵州理工学院 2025-06-17 CN disclosed
CN-118496214-B Preparation method of triglycidyl isocyanurate 黄山华惠科技有限公司 2024-11-01 CN disclosed
CN-221867981-U Industrial production organic waste gas purifying and dedusting equipment 北京卓燕空调净化设备有限公司 2024-10-22 CN disclosed
CN-118496214-A Preparation method of triglycidyl isocyanurate 黄山华惠科技有限公司 2024-08-16 CN disclosed
WO-2024160802-A1 ANTISEPTIC CONDITIONING FORMULATIONS THOMMEN MEDICAL AG (CH) 2024-08-08 WO disclosed
CN-117059456-A Multi-fuse wiring device and wiring method 晏利华 2023-11-14 CN disclosed
CN-108467942-A A method of Selectively leaching zinc, lead, gallium and germanium from zinc replacement slag 武汉科技大学 2018-08-31 CN disclosed
EP-2516729-B1 A BRASS COATED WIRE WITH A ZINC GRADIENT IN THE COATING AND ITS METHOD OF MANUFACTURING BEKAERT SA NV (BE) 2015-07-29 EP disclosed
US-20140069819-A1 ZINC OXIDE NANOFLAKES FOR TREATMENT OF POLLUTANTS FARRUKH MUHAMMAD AKHYAR (PK) 2014-03-13 US disclosed
US-7427663-B2 Cardio myopeptidin, the production and the use thereof DALIAN ZHEN-AO PHARMACEUTICAL CO., LTD. (CN) 2008-09-23 US disclosed
EP-1959933-A1 PROCESS FOR THE PERPARATION OF LYOPHILIZED PIPERACILLINE SODIUM WITH IMPROVED STABILITY AFTER RECONSTITUTION Sandoz AG (CH) 2008-08-27 EP disclosed
WO-2007104361-A1 NANOFIBERS FROM FUNCTIONALIZED ORGANIC MOLECULES CARL VON OSSIETZKY UNIVERSITÄT OLDENBURG (DE) 2007-09-20 WO disclosed
EP-1835007-A2 Nanofibres from functionalised organic molecules Carl von Ossietzky Universität Oldenburg (DE) 2007-09-19 EP disclosed
WO-2007065862-A1 PROCESS FOR THE PERPARATION OF LYOPHILIZED PIPERACILLINE SODIUM WITH IMPROVED STABILITY AFTER RECONSTITUTION SANDOZ AG (CH) 2007-06-14 WO disclosed
US-20070117745-A1 Cardio myopeptidin, the production and the use thereof DALIAN ZHEN-AO PHARMACEUTICAL CO., LTD. (CN) 2007-05-24 US disclosed
EP-1749796-A1 Method for generating hydrogen gas Air Products and Chemicals, Inc. (US) 2007-02-07 EP disclosed
US-20070020174-A1 Method for generating hydrogen gas AIR PRODUCTS AND CHEMICALS, INC. 2007-01-25 US disclosed
EP-1661907-A1 A CARDIO MYOPEPTIDIN, THE PRODUCTION AND THE USE THEREOF Dalian Zhen-Ao Pharmaceutical Co., Ltd. (CN) 2006-05-31 EP disclosed
US-4384108-A Two-phase interfacial polycarbonate process GENERAL ELECTRIC COMPANY (US) 1983-05-17 US disclosed